US541A - Daniel desmond - Google Patents

Daniel desmond Download PDF

Info

Publication number
US541A
US541A US541DA US541A US 541 A US541 A US 541A US 541D A US541D A US 541DA US 541 A US541 A US 541A
Authority
US
United States
Prior art keywords
grate
desmond
flue
daniel
cooking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Publication date
Application granted granted Critical
Publication of US541A publication Critical patent/US541A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F24HEATING; RANGES; VENTILATING
    • F24BDOMESTIC STOVES OR RANGES FOR SOLID FUELS; IMPLEMENTS FOR USE IN CONNECTION WITH STOVES OR RANGES
    • F24B1/00Stoves or ranges
    • F24B1/18Stoves with open fires, e.g. fireplaces
    • F24B1/182Stoves with open fires, e.g. fireplaces with additional provisions for cooking

Definitions

  • Patented Dc 26. 1837.
  • my invention consists in attaching to a fire-place a grate and flue so arranged that they may be drawn outward from the fireplace so as to throw the heat more into the room, or for the purpose of cooking upon the grate without occasioning smoke.
  • the grate is made to draw out from the fire-place ten or twelve inches, more or less, for the purpose of giving out more heat, or for the purpose of cooking to which it is particularly applicable.
  • the flue is so elongated as to pass in under the oven and within the main flue, so that when the grate is drawn out the passage for the smoke remains the same, only lengthened, and the draughtequally good.
  • An air-tight plate and collar, (D. Figs. 8 and 4) is made through which the sliding flue passes. This prevents the air passing up the chimney,
  • This grate can be adapted for cooking or fora parlor grate.
  • That part of it marked in the drawing as K. Figs. 1, 3 & 4, is omitted and a plain grate substituted, the flue being made to slide in and out with it, as in the one for cooking.
  • the oven may also be omitted in the parlor stove if desired, I
  • WVhat I claim as my invention and desire to secure by Letters Patent is The principle of drawing out the flue with the grate so as to preserve an equally good draught and yet adapt the grate for the purposes of cooking or give out more heat into the room.

Landscapes

  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Combustion & Propulsion (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Baking, Grill, Roasting (AREA)

Description

D. DESMOND.
I Fire Place. N0. 541
Patented Dc; 26. 1837.
Witnesses:
I In o entor; V
n TED STATES PATENT OFFICE.
DANIEL DESMOND, OF NEW YORK, N. Y.
SLIDING-FLUE GR-ATE.
Specification of Letters Patent No. 541, dated December 26, 1837.
To all whom it may concern:
Be it known that I, DANIEL DESMOND, of the city, county, and State of New York, have invented a new and useful Improvement in Grates, called Desmonds Sliding- Flue Grate; and I do hereby declare that the following is a full and exact description.
The nature of my invention consists in attaching to a fire-place a grate and flue so arranged that they may be drawn outward from the fireplace so as to throw the heat more into the room, or for the purpose of cooking upon the grate without occasioning smoke.
To enable others skilled in the business to make and use my invention I herewith describe its construction and operation.
Its general appearance is that of a parlor grate except when drawn out. It is constructed with a fire-place attached so that it may be set in the middle of a room if desirable, as a stove or franklin, a pipe being added to convey the smoke to the chimney, or it may be placed in any ordinary fire place and will be at once ready for use as no masonry is required to set it. An oven is attached, (see annexed drawing, Figures 3 and 4, C) on every side of which, if desired, the smoke passes. It is closed by two doors (I, Figs. 1 & 2) in front which are made to slide. The grate is made to draw out from the fire-place ten or twelve inches, more or less, for the purpose of giving out more heat, or for the purpose of cooking to which it is particularly applicable. The flue is so elongated as to pass in under the oven and within the main flue, so that when the grate is drawn out the passage for the smoke remains the same, only lengthened, and the draughtequally good. An air-tight plate and collar, (D. Figs. 8 and 4) is made through which the sliding flue passes. This prevents the air passing up the chimney,
otherwise than through the proper flue,
when the grate is'drawn out. This grate can be adapted for cooking or fora parlor grate. When not intended for cooking, that part of it, marked in the drawing as K. Figs. 1, 3 & 4, is omitted and a plain grate substituted, the flue being made to slide in and out with it, as in the one for cooking. The oven may also be omitted in the parlor stove if desired, I
but it can be retained without injuring the appearance of the parlor grate. To enable the grate to move out easily the pieces marked G. Figs. 3 &,4l, are extended back upon rollers, (E E Figs. 3 and 4:). The roller F. Fig. 3, is placed above the lower bar G. to prevent the grate sinking down when drawn out.
WVhat I claim as my invention and desire to secure by Letters Patent is The principle of drawing out the flue with the grate so as to preserve an equally good draught and yet adapt the grate for the purposes of cooking or give out more heat into the room.
OWEN Gr. WARREN, HENRY BART O EMEW,
US541D Daniel desmond Expired - Lifetime US541A (en)

Publications (1)

Publication Number Publication Date
US541A true US541A (en) 1837-12-26

Family

ID=2060820

Family Applications (1)

Application Number Title Priority Date Filing Date
US541D Expired - Lifetime US541A (en) Daniel desmond

Country Status (1)

Country Link
US (1) US541A (en)

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100251928A1 (en) * 2008-03-07 2010-10-07 Xerox Corporation Nonpolar liquid and solid phase change ink compositions comprising nanosized particles of benzimidazolone pigments
WO2012089814A1 (en) 2010-12-30 2012-07-05 INSERM (Institut National de la Santé et de la Recherche Médicale) Antigen binding formats for use in therapeutic treatments or diagnostic assays
US20120233729P1 (en) * 2011-03-11 2012-09-13 Cp Delaware, Inc. Climbing rose plant named 'Meilaclost'
WO2017158396A1 (en) 2016-03-16 2017-09-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Cytidine deaminase inhibitors for the treatment of pancreatic cancer
WO2018141753A1 (en) 2017-01-31 2018-08-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for treating squamous cell carcinomas
WO2020049130A1 (en) 2018-09-05 2020-03-12 Valerie Nicholas Carl Kristoffer Methods
WO2020148349A1 (en) 2019-01-16 2020-07-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Variants of erythroferrone and their use
WO2020193740A1 (en) 2019-03-28 2020-10-01 INSERM (Institut National de la Santé et de la Recherche Médicale) New strategy for treating pancreatic cancer
WO2020208082A1 (en) 2019-04-09 2020-10-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for treating cmv related diseases
WO2020245160A1 (en) 2019-06-03 2020-12-10 Fenomark Diagnostics Ab Medical uses, methods and uses
WO2021105391A1 (en) 2019-11-27 2021-06-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Combination comprising nupr1 inhibitors to treat cancer
WO2021105384A1 (en) 2019-11-27 2021-06-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Targeting the nls region of nupr1 protein to treat cancer
WO2021233962A1 (en) 2020-05-19 2021-11-25 Institut Curie Methods for the diagnosis and treatment of cytokine release syndrome
WO2021255204A1 (en) 2020-06-18 2021-12-23 INSERM (Institut National de la Santé et de la Recherche Médicale) New strategy for treating pancreatic cancer
WO2022084399A1 (en) 2020-10-21 2022-04-28 INSERM (Institut National de la Santé et de la Recherche Médicale) C-terminal sparc fragments for treating cancer
WO2022162192A2 (en) 2021-01-29 2022-08-04 Thelper As Therapeutic and diagnostic agents and uses thereof
WO2022219076A1 (en) 2021-04-14 2022-10-20 INSERM (Institut National de la Santé et de la Recherche Médicale) New method to improve the anti-tumoral activity of macrophages
WO2022219080A1 (en) 2021-04-14 2022-10-20 INSERM (Institut National de la Santé et de la Recherche Médicale) New method to improve nk cells cytotoxicity
WO2022253910A1 (en) 2021-06-02 2022-12-08 INSERM (Institut National de la Santé et de la Recherche Médicale) A new method to treat an inflammatory skin disease
WO2023012343A1 (en) 2021-08-06 2023-02-09 Institut Du Cancer De Montpellier Methods for the treatment of cancer
WO2023041805A1 (en) 2021-09-20 2023-03-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for improving the efficacy of hdac inhibitor therapy and predicting the response to treatment with hdac inhibitor
WO2023041744A1 (en) 2021-09-17 2023-03-23 Institut Curie Bet inhibitors for treating pab1 deficient cancer
WO2023057484A1 (en) 2021-10-06 2023-04-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting and improving the efficacy of mcl-1 inhibitor therapy
WO2023073099A1 (en) 2021-10-28 2023-05-04 INSERM (Institut National de la Santé et de la Recherche Médicale) Method to improve phagocytosis
WO2023078906A1 (en) 2021-11-03 2023-05-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for treating acute myeloid leukemia
WO2023089159A1 (en) 2021-11-22 2023-05-25 INSERM (Institut National de la Santé et de la Recherche Médicale) New strategy targeting stroma/tumor cell crosstalk to treat a cancer
WO2023089032A1 (en) 2021-11-19 2023-05-25 Institut Curie Methods for the treatment of hrd cancer and brca-associated cancer
WO2023099763A1 (en) 2021-12-03 2023-06-08 Institut Curie Sirt6 inhibitors for use in treating resistant hrd cancer
WO2024028476A1 (en) 2022-08-05 2024-02-08 Institut National de la Santé et de la Recherche Médicale Methods for the treatment of th2-mediated diseases
WO2024037910A1 (en) 2022-08-17 2024-02-22 Institut National de la Santé et de la Recherche Médicale Syk inhibitors for use in the treatment of cancer
WO2024133723A1 (en) 2022-12-22 2024-06-27 Institut National de la Santé et de la Recherche Médicale Methods for decreasing therapeutic acquired resistance to chemotherapy and/or radiotherapy
WO2024184479A1 (en) 2023-03-08 2024-09-12 Institut National de la Santé et de la Recherche Médicale Methods for the treatment of food allergy
WO2024184476A1 (en) 2023-03-07 2024-09-12 Institut Curie Ung/udg inhibition in brca-associated cancer
WO2024194401A1 (en) 2023-03-21 2024-09-26 Institut Curie Vps4b inhibitor for use in methods for the treatment of hrd cancer
WO2024194692A1 (en) 2023-03-21 2024-09-26 Institut Curie Tgf-beta inhibitor for use in the treatment of dedifferentiated liposarcoma
WO2024194402A1 (en) 2023-03-21 2024-09-26 Institut Curie Farnesyl transferase inhibitor for use in methods for the treatment of hrd cancer
WO2024213782A1 (en) 2023-04-13 2024-10-17 Institut Curie Methods for the treatment of t-cell acute lymphoblastic leukemia

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100251928A1 (en) * 2008-03-07 2010-10-07 Xerox Corporation Nonpolar liquid and solid phase change ink compositions comprising nanosized particles of benzimidazolone pigments
WO2012089814A1 (en) 2010-12-30 2012-07-05 INSERM (Institut National de la Santé et de la Recherche Médicale) Antigen binding formats for use in therapeutic treatments or diagnostic assays
US20120233729P1 (en) * 2011-03-11 2012-09-13 Cp Delaware, Inc. Climbing rose plant named 'Meilaclost'
WO2017158396A1 (en) 2016-03-16 2017-09-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Cytidine deaminase inhibitors for the treatment of pancreatic cancer
WO2018141753A1 (en) 2017-01-31 2018-08-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for treating squamous cell carcinomas
WO2020049130A1 (en) 2018-09-05 2020-03-12 Valerie Nicholas Carl Kristoffer Methods
WO2020148349A1 (en) 2019-01-16 2020-07-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Variants of erythroferrone and their use
WO2020193740A1 (en) 2019-03-28 2020-10-01 INSERM (Institut National de la Santé et de la Recherche Médicale) New strategy for treating pancreatic cancer
WO2020208082A1 (en) 2019-04-09 2020-10-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for treating cmv related diseases
WO2020245160A1 (en) 2019-06-03 2020-12-10 Fenomark Diagnostics Ab Medical uses, methods and uses
WO2021105391A1 (en) 2019-11-27 2021-06-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Combination comprising nupr1 inhibitors to treat cancer
WO2021105384A1 (en) 2019-11-27 2021-06-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Targeting the nls region of nupr1 protein to treat cancer
WO2021233962A1 (en) 2020-05-19 2021-11-25 Institut Curie Methods for the diagnosis and treatment of cytokine release syndrome
EP4424711A2 (en) 2020-05-19 2024-09-04 Institut Curie Methods for the diagnosis and treatment of cytokine release syndrome
WO2021255204A1 (en) 2020-06-18 2021-12-23 INSERM (Institut National de la Santé et de la Recherche Médicale) New strategy for treating pancreatic cancer
WO2022084399A1 (en) 2020-10-21 2022-04-28 INSERM (Institut National de la Santé et de la Recherche Médicale) C-terminal sparc fragments for treating cancer
WO2022162192A2 (en) 2021-01-29 2022-08-04 Thelper As Therapeutic and diagnostic agents and uses thereof
WO2022219076A1 (en) 2021-04-14 2022-10-20 INSERM (Institut National de la Santé et de la Recherche Médicale) New method to improve the anti-tumoral activity of macrophages
WO2022219080A1 (en) 2021-04-14 2022-10-20 INSERM (Institut National de la Santé et de la Recherche Médicale) New method to improve nk cells cytotoxicity
WO2022253910A1 (en) 2021-06-02 2022-12-08 INSERM (Institut National de la Santé et de la Recherche Médicale) A new method to treat an inflammatory skin disease
WO2023012343A1 (en) 2021-08-06 2023-02-09 Institut Du Cancer De Montpellier Methods for the treatment of cancer
WO2023041744A1 (en) 2021-09-17 2023-03-23 Institut Curie Bet inhibitors for treating pab1 deficient cancer
WO2023041805A1 (en) 2021-09-20 2023-03-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for improving the efficacy of hdac inhibitor therapy and predicting the response to treatment with hdac inhibitor
WO2023057484A1 (en) 2021-10-06 2023-04-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting and improving the efficacy of mcl-1 inhibitor therapy
WO2023073099A1 (en) 2021-10-28 2023-05-04 INSERM (Institut National de la Santé et de la Recherche Médicale) Method to improve phagocytosis
WO2023078906A1 (en) 2021-11-03 2023-05-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for treating acute myeloid leukemia
WO2023089032A1 (en) 2021-11-19 2023-05-25 Institut Curie Methods for the treatment of hrd cancer and brca-associated cancer
WO2023089159A1 (en) 2021-11-22 2023-05-25 INSERM (Institut National de la Santé et de la Recherche Médicale) New strategy targeting stroma/tumor cell crosstalk to treat a cancer
WO2023099763A1 (en) 2021-12-03 2023-06-08 Institut Curie Sirt6 inhibitors for use in treating resistant hrd cancer
WO2024028476A1 (en) 2022-08-05 2024-02-08 Institut National de la Santé et de la Recherche Médicale Methods for the treatment of th2-mediated diseases
WO2024037910A1 (en) 2022-08-17 2024-02-22 Institut National de la Santé et de la Recherche Médicale Syk inhibitors for use in the treatment of cancer
WO2024133723A1 (en) 2022-12-22 2024-06-27 Institut National de la Santé et de la Recherche Médicale Methods for decreasing therapeutic acquired resistance to chemotherapy and/or radiotherapy
WO2024184476A1 (en) 2023-03-07 2024-09-12 Institut Curie Ung/udg inhibition in brca-associated cancer
WO2024184479A1 (en) 2023-03-08 2024-09-12 Institut National de la Santé et de la Recherche Médicale Methods for the treatment of food allergy
WO2024194401A1 (en) 2023-03-21 2024-09-26 Institut Curie Vps4b inhibitor for use in methods for the treatment of hrd cancer
WO2024194692A1 (en) 2023-03-21 2024-09-26 Institut Curie Tgf-beta inhibitor for use in the treatment of dedifferentiated liposarcoma
WO2024194402A1 (en) 2023-03-21 2024-09-26 Institut Curie Farnesyl transferase inhibitor for use in methods for the treatment of hrd cancer
WO2024194673A1 (en) 2023-03-21 2024-09-26 Institut Curie Methods for the treatment of dedifferentiated liposarcoma
WO2024213782A1 (en) 2023-04-13 2024-10-17 Institut Curie Methods for the treatment of t-cell acute lymphoblastic leukemia

Similar Documents

Publication Publication Date Title
US541A (en) Daniel desmond
US62A (en) Cooking-stove
US370A (en) Cookingr-stove
US304A (en) David w
US363308A (en) Half to a
US453765A (en) Shutter for fire-grates
US60453A (en) Jambs wilson
US249A (en) Opettf itkeplace ob
US1479A (en) Mode oe constructing the draft of chimneys
US9780A (en) Stove
US3655A (en) Cooking-stove
US784A (en) Thomas whitson
US579987A (en) Grate-front
US205A (en) Stove-radiator
US226356A (en) Grate for fire-places
US1094659A (en) Fireplace.
US150680A (en) Improvement in fire-place grates
US462520A (en) Hood for fire-places
US418714A (en) John wool griswold
US1601A (en) Joel hotjghton
US1827A (en) Cooking-stove
US1360619A (en) Stove and fireplace
US493A (en) Cooking-stove
US1389516A (en) killen
US71A (en) Parlob